ARTICLE | Company News
Pharmagenesis, Fujisawa deal
September 30, 2002 7:00 AM UTC
The companies will research the use of triptolide derivatives from Pharmagenesis to treat autoimmune conditions. Fujisawa has an option to acquire the exclusive worldwide development and marketing rig...